BML Share Price | Synthaverse SA Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare Synthaverse SA with Similar Stocks

Captor Therapeutics SA Celon Pharma SA Ryvu Therapeutics SA

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Poor Management Efficiency with a low ROE of 6.11%

The company has been able to generate a Return on Equity (avg) of 6.11% signifying low profitability per unit of shareholders funds

The company is Net-Debt Free

Poor long term growth as Net Sales has grown by an annual rate of 5.68% over the last 5 years

With a fall in Net Sales of -40.15%, the company declared Very Negative results in Sep 25

Risky -

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

PLN 261 Million (Small Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.64

Return on Equity

-4.64%

Price to Book

2.00

Revenue and Profits:

Net Sales:

18 Million

(Quarterly Results - Dec 2025)

Net Profit:

-7 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-17.76%

6 Months

-24.51%

1 Year

-42.43%

2 Years

-39.37%

3 Years

-46.39%

4 Years

-2.75%

5 Years

-69.8%

Synthaverse SA for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

5.68%

EBIT Growth (5y)

-191.13%

EBIT to Interest (avg)

5.05

Debt to EBITDA (avg)

1.90

Net Debt to Equity (avg)

0.70

Sales to Capital Employed (avg)

0.33

Tax Ratio

26.69%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

9.25%

ROE (avg)

6.11%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.16

EV to EBIT

-125.84

EV to EBITDA

38.13

EV to Capital Employed

1.71

EV to Sales

6.81

PEG Ratio

Dividend Yield

ROCE (Latest)

-1.36%

ROE (Latest)

-4.64%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -40.07% vs 45.27% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -198.57% vs 79.49% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "17.50",
          "val2": "29.20",
          "chgp": "-40.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.90",
          "val2": "11.90",
          "chgp": "-141.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.40",
          "val2": "0.90",
          "chgp": "55.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.90",
          "val2": "7.00",
          "chgp": "-198.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-462.40%",
          "val2": "324.90%",
          "chgp": "-78.73%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -41.50% vs 22.53% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -361.84% vs 58.33% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "42.00",
          "val2": "71.80",
          "chgp": "-41.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-7.30",
          "val2": "20.00",
          "chgp": "-136.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.90",
          "val2": "2.50",
          "chgp": "56.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-19.90",
          "val2": "7.60",
          "chgp": "-361.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-489.80%",
          "val2": "166.60%",
          "chgp": "-65.64%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]